共 131 条
[1]
Celis R(2008)Evidence for activation of immune system in heart failure: is there a role for anti-inflammatory therapy? Curr Opin Cardiol 23 254-60
[2]
Torre-Martinez G(2008)Increased expression of LIGHT/TNFSF14 and its receptors in experimental and clinical heart failure Eur J Heart Fail 10 352-9
[3]
Torre-Amione G(2006)Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure J Am Coll Cardiol 47 332-7
[4]
Dahl CP(2006)Short-term statin treatment improves endothelial function and neurohormonal imbalance in normocholesterolaemic patients with non-ischaemic heart failure Heart 92 1603-9
[5]
Gullestad L(2007)Effect of high-dose atorvastatin on hospitalizations for heart failure: subgroup analysis of the treating to new targets (TNT) study Circulation 115 576-83
[6]
Fevang B(2007)Rosuvastatin in older patients with systolic heart failure N Engl J Med 357 2248-61
[7]
Holm AM(2008)Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial Lancet 372 1231-9
[8]
Landro L(2006)Correlation of flow mediated dilation with inflammatory markers in patients with impaired cardiac function. Beneficial effects of inhibition of ACE Eur J Heart Fail 8 451-9
[9]
Vinge LE(2008)Soluble ICAM-1 and VCAM-1 as markers of endothelial activation Scand J Immunol 67 523-31
[10]
Sola S(2002)Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force J Am Coll Cardiol 39 257-65